ArticlebioRxiv : the preprint server for biology2024

Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.

Zahra Motahari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.